Cargando…

Recent Progress and Challenges for Drug-Resistant Tuberculosis Treatment

Control of Mycobacterium tuberculosis infection continues to be an issue, particularly in countries with a high tuberculosis (TB) burden in the tropical and sub-tropical regions. The effort to reduce the catastrophic cost of TB with the WHO’s End TB Strategy in 2035 is still obstructed by the emerge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stephanie, Filia, Saragih, Mutiara, Tambunan, Usman Sumo Friend
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143172/ https://www.ncbi.nlm.nih.gov/pubmed/33919204 http://dx.doi.org/10.3390/pharmaceutics13050592

Ejemplares similares

Structural Design and Synthesis of Novel Cyclic Peptide Inhibitors Targeting Mycobacterium tuberculosis Transcription
por: Stephanie, Filia, et al.
Publicado: (2022)

M. tuberculosis Transcription Machinery: A Review on the Mycobacterial RNA Polymerase and Drug Discovery Efforts
por: Stephanie, Filia, et al.
Publicado: (2022)

Identification of DNA Methyltransferase-1 Inhibitor for Breast Cancer Therapy through Computational Fragment-Based Drug Design
por: Alkaff, Ahmad Husein, et al.
Publicado: (2021)

Identification of sequence mutations affecting hemagglutinin specificity to sialic acid receptor in influenza A virus subtypes
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2010)

Designing cyclopentapeptide inhibitor as potential antiviral drug for dengue virus ns5 methyltransferase
por: Idrus, Syarifuddin, et al.
Publicado: (2012)

Designing cyclic peptide inhibitor of dengue virus NS3-NS2B protease by using molecular docking approach
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2010)

Identification of a better Homo sapiens Class II HDAC inhibitor through binding energy calculations and descriptor analysis
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2010)

In silico modification of oseltamivir as neuraminidase inhibitor of influenza A virus subtype H1N1
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2015)

Exposing the Molecular Screening Method of Indonesian Natural Products Derivate as Drug Candidates for Cervical Cancer
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2017)

Flexible docking-based molecular dynamics simulation of natural product compounds and Ebola virus Nucleocapsid (EBOV NP): a computational approach to discover new drug for combating Ebola
por: Nasution, Mochammad Arfin Fardiansyah, et al.
Publicado: (2018)

Screening of commercial cyclic peptide as inhibitor NS5 methyltransferase of Dengue virus through Molecular Docking and Molecular Dynamics Simulation
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2014)

Immunoinformatics Approach in Designing Epitope-based Vaccine Against Meningitis-inducing Bacteria (Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae Type b)
por: Zahroh, Hilyatuz, et al.
Publicado: (2016)

Molecular dynamics simulation of complex Histones Deacetylase (HDAC) Class II Homo Sapiens with suberoylanilide hydroxamic acid (SAHA) and its derivatives as inhibitors of cervical cancer
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2013)

Vaccine Design for H5N1 Based on B- and T-cell Epitope Predictions
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2016)

Utilization of Boron Compounds for the Modification of Suberoyl Anilide Hydroxamic Acid as Inhibitor of Histone Deacetylase Class II Homo sapiens
por: Bakri, Ridla, et al.
Publicado: (2014)

Modification of S-Adenosyl-l-Homocysteine as Inhibitor of Nonstructural Protein 5 Methyltransferase Dengue Virus Through Molecular Docking and Molecular Dynamics Simulation
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2017)

Challenges & Solutions for Recent Advancements in Multi-Drugs Resistance Tuberculosis: A Review
por: Yadav, Pramod
Publicado: (2023)

Latent tuberculosis infection: recent progress and challenges in South Korea
por: Jeon, Doosoo
Publicado: (2020)

Drug-resistant tuberculosis control in China: progress and challenges
por: Long, Qian, et al.
Publicado: (2016)

Recent Progress in the Development of Novel Mycobacterium Cell Wall Inhibitor to Combat Drug-Resistant Tuberculosis
por: Belete, Tafere Mulaw
Publicado: (2022)

Challenges and recent progress in drug discovery for tropical diseases
por: De Rycker, Manu, et al.
Publicado: (2018)

Evolution of Drug Resistance in Tuberculosis: Recent Progress and Implications for Diagnosis and Therapy
por: Trauner, Andrej, et al.
Publicado: (2014)

Challenges and Recent Progress in Oral Drug Delivery Systems for Biopharmaceuticals
por: Homayun, Bahman, et al.
Publicado: (2019)

Anti-Obesity Drug Delivery Systems: Recent Progress and Challenges
por: Ashour, Mohamed M., et al.
Publicado: (2023)

Deciphering drug resistance in Mycobacterium tuberculosis using whole-genome sequencing: progress, promise, and challenges
por: Cohen, Keira A., et al.
Publicado: (2019)

Recent progress and challenges in the treatment of spinal cord injury
por: Tian, Ting, et al.
Publicado: (2023)

Challenges in the development of drugs for the treatment of tuberculosis
por: Shehzad, Adeeb, et al.
Publicado: (2013)

Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment
por: Koch, Anastasia, et al.
Publicado: (2018)

Drug-resistant tuberculosis and advances in the treatment of childhood tuberculosis
por: Seddon, James A., et al.
Publicado: (2016)

Machine learning approaches to drug response prediction: challenges and recent progress
por: Adam, George, et al.
Publicado: (2020)

Recent Progress and Challenges in the Diagnosis and Treatment of Gastrointestinal Stromal Tumors
por: Nishida, Toshirou, et al.
Publicado: (2021)

Tackling Drug-Resistant Tuberculosis: New Challenges from the Old Pathogen Mycobacterium tuberculosis
por: Mancuso, Giuseppe, et al.
Publicado: (2023)

Recent progress in drug delivery
por: Li, Chong, et al.
Publicado: (2019)

Recent Progress in Characterizing Long Noncoding RNAs in Cancer Drug Resistance
por: Zhao, Wenyuan, et al.
Publicado: (2019)

Neoadjuvant Treatment for Triple Negative Breast Cancer: Recent Progresses and Challenges
por: Lee, Jin Sun, et al.
Publicado: (2020)

Drug-resistant tuberculosis: emerging treatment options
por: Adhvaryu, Meghna, et al.
Publicado: (2011)

The role of delamanid in the treatment of drug-resistant tuberculosis
por: Lewis, Joseph M, et al.
Publicado: (2015)

Recent Advances in Multi-Drug-Resistant Tuberculosis and RNTCP
por: Grover, Gagandeep Singh, et al.
Publicado: (2008)

Recently developed drugs for the treatment of drug-resistant tuberculosis: a research and development case study
por: Perrin, Christophe, et al.
Publicado: (2022)

Translation of Polymeric Microneedles for Treatment of Human Diseases: Recent Trends, Progress, and Challenges
por: Yadav, Prateek Ranjan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aas9mq2gtt70maofslmfg6i7b0